CALR and neoplasm: Anthracyclines can induce the translocation of calreticulin from the cytoplasm to cell surface in tumour cells, which leads to their recognition by dendritic cells (DCs) and tumour antigen processing and presentation to CD4+ T and CD8+ T cells, thereby stimulating the antitumour immune response.